Covered recipient · General Payments record
MARCELA A MONTES
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,684.46
- Reported across 57 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $536.26 | 16 |
| Travel and Lodging | $13.54 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $403.38 | 12 |
| BOSTON SCIENTIFIC CORPORATION | $76.95 | 2 |
| Novo Nordisk AS | $43.33 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $26.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $26.14 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118122405 | CMS |
| Boston Scientific Corporation | $38.47 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092706946 | CMS |
| Boston Scientific Corporation | $38.48 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092706948 | CMS |
| Lilly USA, LLC | $31.01 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135832451 | CMS |
| Lilly USA, LLC | $33.19 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135808933 | CMS |
| Lilly USA, LLC | $122.11 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135754851 | CMS |
| Lilly USA, LLC | $13.54 | 02/20/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1135808931 | CMS |
| Lilly USA, LLC | $27.12 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135832455 | CMS |
| Lilly USA, LLC | $19.26 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135742810 | CMS |
| Lilly USA, LLC | $17.76 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135801962 | CMS |
| Lilly USA, LLC | $32.52 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135832459 | CMS |
| Lilly USA, LLC | $34.01 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135804266 | CMS |
| Lilly USA, LLC | $26.91 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135772491 | CMS |
| Lilly USA, LLC | $34.49 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135808935 | CMS |
| Lilly USA, LLC | $11.46 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135808929 | CMS |
| Novo Nordisk Inc | $20.60 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100256066 | CMS |
| Novo Nordisk Inc | $22.73 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100635887 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.